Evogene considers trading on U.S. markets
In Israel, Evogene may be looking to trade in the North American markets after spinning off from Compugen Ltd in 2007. They are currently looking for a market where the “expertise of the agricultural sector high,” said Ofer Haviv, CEO. “We are currently in the Tel Aviv 100 Index, but that’s not enough.” The company has a market value of $200 million, with a .29 percent weight in the capitalization-weighted index of 100 stocks traded in Tel Aviv.
Category: Fuels
